PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-20

Date Title Company
20-Feb-2024 Variscite Teams with Crank to Deliver Custom GUI Development Solutions for Embedded Devices Businesswire
20-Feb-2024 NHI Issues Investor Update AccessWire
20-Feb-2024 NHI Announces First Quarter 2024 Dividend AccessWire
20-Feb-2024 NHI Announces Fourth Quarter 2023 Results AccessWire
20-Feb-2024 Protagonist Therapeutics Reports Granting of Inducement Awards AccessWire
20-Feb-2024 Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024 AccessWire
20-Feb-2024 China Oncology Drugs Market Research Report 2024-2028 Featuring Major Players - Bristol Myers Squibb, Merck, Eli Lilly, Sino BioPharma, F Hoffmann-La Roche, Johnson & Johnson, AbbVie, AstraZeneca - ResearchAndMarkets.com Businesswire
20-Feb-2024 Boveda Inc. Collaborates With ICQSA to Advance International Cannabis Quality Frameworks Businesswire
20-Feb-2024 Bioscience Association Manitoba to Host Annual Awards Dinner to Celebrate Achievements in Manitoba’s Bioscience Industry Businesswire
20-Feb-2024 University Medical Devices Raises $1.6 Million in Seed Funding to Launch First-of-its-Kind Nasal Specimen Collection Device for Diagnosing Upper Respiratory Infections Businesswire
20-Feb-2024 Eurofins MET Labs Recognized for Instrumental Support in Intuitive Machines’ IM-1 Lunar Mission Businesswire
20-Feb-2024 OcuSciences Welcomes Michael Patane, PhD, to its Board of Directors Businesswire
20-Feb-2024 Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement Businesswire
20-Feb-2024 Principal IRB Becomes Univo IRB With Support From QHP Capital Businesswire
20-Feb-2024 Arcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024 Businesswire
20-Feb-2024 Devonian Bolsters Intellectual Property With Issuance of U.S. Patent Covering a Method of Treatment of Inflammatory Bowel Disease Businesswire
20-Feb-2024 Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting Businesswire
20-Feb-2024 Blue Earth Therapeutics Announces Publication of Results from Independent Clinical Experience with 177Lu-rhPSMA-10.1 in Treatment of Metastatic Castrate Resistant Prostate Cancer Businesswire
20-Feb-2024 Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees Businesswire
20-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire